Baixar PDF

Outros usuários também visualizaram estes artigos

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;
Hematol Transfus Cell Ther. 2025;47:
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;
Hematol Transfus Cell Ther. 2024;46:268-72
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel Elvira D. Rodrigues Pereira Velloso; Geórgia A. Padulla; Ana Maria Mósca de Cerqueira; Adriana Martins de Sousa; Alex Freire Sandes; Fabiola Traina; Fernanda Salles Seguro; Frederico Lisboa Nogueira; Grazielly de Fátima Pereira; José Laerte Boechat; Katia Borgia Barbosa Pagnano; Luan Lima Marchi; Luis Felipe Ensina; Mara Giavina-Bianchi; Marcelo Vivolo Aun; Rosana Câmara Agondi; Fabio Pires de Souza Santos; Pedro Giavina-Bianchi;
Hematol Transfus Cell Ther. 2022;44:582-94